EFFECT OF A PROGESTIN-ESTROGEN ORAL CONTRACEPTIVE ON BLOOD CLOTTING FACTORS.
D035843:Biomedical Research; D001777:Blood Coagulation; D001779:Blood Coagulation Factors; D003276:Contraceptives, Oral; D004967:Estrogens; D005165:Factor V; D005167:Factor VII; D005169:Factor VIII; D005170:Factor X; D005260:Female; D006801:Humans; D008656:Mestranol; D009640:Norethindrone; D010600:Pharmacology; D011372:Progestins; D011516:Prothrombin; D013923:Thromboembolism; D014116:Toxicology
D001779:Blood Coagulation Factors; D003276:Contraceptives, Oral; D004967:Estrogens; D011372:Progestins; C427184:recombinant factor VIII SQ; D005165:Factor V; D005167:Factor VII; D011516:Prothrombin; D005169:Factor VIII; D005170:Factor X; D008656:Mestranol; D009640:Norethindrone
BLOOD COAGULATION FACTORS; CLINICAL RESEARCH; FACTOR V; FACTOR VII; FACTOR VIII; FACTOR X; MESTRANOL; NORETHINDRONE; PHARMACOLOGY; PROTHROMBIN; THROMBOEMBOLISM; TOXICOLOGIC REPORT